25 July 2022>: Database Analysis
Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (−)-Guaiol Against Lung Adenocarcinoma
Yaoying Zeng 1E* , Yanbin Pan 1B* , Bo Zhang 1C , Yingbin Luo 1D , Jianhui Tian 1AF , Yuli Wang 1CD , Xudong Ju 2BF , Jianchun Wu 1A* , Yan Li 1A*DOI: 10.12659/MSM.937131
Med Sci Monit 2022; 28:e937131
Figure 7 Molecular docking diagrams of (−)-Guaiol with (A) CDK2, (B) EGFR, (C) HSP90AA1, (D) HSP90AB1, and (E) FN1. (F) The binding affinity for the 5 targets docked into the (−)-Guaiol crystal structure.